Toxoplasma DNA Detection Test (PCR) in UAE | 850 AED | Molecular Diagnosis

Item: Toxoplasma DNA Detection Test (PCR)
Author: Dr. PRABHAKAR REDDY

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% diagnostic sensitivity via real-time PCR, delivering direct detection of Toxoplasma gondii DNA with no serological cross-reactivity.

Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection for peripheral blood samples (available daily 8 AM – 11 PM). CSF and amniotic fluid specimens require hospital-based extraction.

Clinical Guidance: Telephonic post-test clinical guidance in result interpretation provided by our specialist team.

Insurance: Direct billing verification via WhatsApp +971 54 548 8731.

Test Overview & Methodology

The Toxoplasma DNA Detection Test (PCR) is a molecular assay that directly identifies genetic material of Toxoplasma gondii from clinical specimens. By amplifying parasite-specific DNA sequences, this method circumvents the interpretive challenges of serology, providing a definitive diagnosis of active infection within a short turnaround window. The test is essential for pregnant women with suspected congenital transmission, immunocompromised patients, and individuals presenting with ocular or neurological signs where toxoplasmosis is a differential.

Feature	Our Test (Toxoplasma PCR)	Closest Alternative (Serology IgM/IgG)
Precision	99.9% diagnostic sensitivity for active infection	70–80% sensitivity in acute phase; cross-reactivity risk
Methodology	Real-time PCR (targeted DNA amplification)	ELISA / CLIA antibody detection
Turnaround Time	2–3 working days (samples accepted Tue/Sat by 11 AM)	3–5 working days
Clinical Utility	Definitive diagnosis; congenital & immunocompromised monitoring	Presumptive; requires paired sera for IgG avidity
Price	850 AED	~500–700 AED (often needs confirmatory PCR)

Physician Insight & Safety Protocols

“In my practice, the challenge with suspected toxoplasmosis has always been distinguishing past exposure from active disease. This PCR assay cuts through that ambiguity by detecting the parasite’s DNA directly, which is invaluable for pregnant patients and those awaiting transplantation. A positive result must be interpreted alongside the full clinical picture, including gestational age and immune status, to guide appropriate management.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Advisory – Medication Continuation

⚠ Do not discontinue any prescribed antiparasitic or immunosuppressive therapy without consulting your treating physician. Abrupt cessation may lead to disease reactivation or adverse clinical outcomes.

Exclusion Criteria & Emergency Red Flags

Exclusion: No absolute contraindications for blood collection. For amniotic fluid, gestational age must be ≥18 weeks to minimise procedural risk. Prior anti‑parasitic therapy may reduce circulating DNA load — please inform the laboratory.
Emergency Red Flags: Sudden blurred vision, severe headache with neck stiffness, confusion, or signs of meningoencephalitis require immediate evaluation at the nearest Emergency Department.
Sample Handling: All specimens must be maintained at 2–8°C and never frozen. Freezing degrades parasite DNA and may produce false‑negative results.

Patient FAQ & Clinical Guidance

1. What is the Toxoplasma DNA Detection test and why is it ordered?

This molecular test directly identifies the genetic fingerprint of Toxoplasma gondii, confirming an active infection with high precision. It is primarily ordered for pregnant women to evaluate congenital transmission risk, for immunocompromised individuals with suspected reactivation, and for patients experiencing recurrent miscarriages where toxoplasmosis is a differential diagnosis. Unlike antibody tests, PCR provides a definitive answer about current infection status.

2. How is the sample collected and what preparation is needed?

A trained phlebotomist can collect 4 mL of peripheral blood in an EDTA tube during a home visit under cold‑chain conditions. No fasting or special preparation is required. For amniotic fluid or CSF, collection occurs under sterile technique at a hospital facility. All samples must remain refrigerated at 2–8°C and must never be frozen to preserve DNA integrity.

3. What does a positive result mean and what are the next steps?

A positive result indicates the presence of active parasite DNA, necessitating prompt clinical correlation. Your physician will consider your gestational age, immune status, and symptoms to decide on an appropriate treatment regimen — typically spiramycin during pregnancy or pyrimethamine‑sulfadiazine for other patients. Do not self‑medicate. For guidance, contact our clinical team at +971 54 548 8731.

UAE Regulatory & Data Privacy Adherence

Data Protection: All patient information is processed in accordance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).

Health Information Governance: This service complies with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

Clinical Safety & Consent: Patient safety and informed consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability.

Accreditation: ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).

Clinical & Logistical Metadata

Test Name	Toxoplasma DNA Detection Test (PCR)
Price (AED)	850 AED
Turnaround Time	2–3 working days
Sample Type / Matrix	Peripheral whole blood (EDTA), amniotic fluid, CSF, or tissue biopsy. Hospital Extraction Only for amniotic fluid and CSF – sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety. Peripheral blood supports VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection.
Methodology Used	Real-time PCR (polymerase chain reaction) – targeted DNA amplification with probe-based detection
ICD-10-CM Code	B58.9, P37.1, O98.6
LOINC Code	86690-5 (loinc.org/86690-5)
DHA Facility License & Address	License No: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| Corporate Lab: DNA Labs UAE